Historically, clinical trials for smoking cessation were evaluated by their efficacy, measured as the percentage of participants who were abstinent at long-term follow-up. If one smoking cessation program generated abstinence rates of 30%, it would be judged to be 50% more efficacious than a program generating only 20% abstinence. The problem was that the best practices in smoking cessation as measured by efficacy typically generated 1% or less participation, even when offered for free.
that can advance behavioral change theories, improve behavioral sciences, enhance prevention practices, and provide a more solid foundation for integrating policies and programs for the prevention and control of chronic diseases. This article reviews programmatic research based on the Transtheoretical Model (TTM) designed to increase the impact on population cessation, and examines how such research could better support population cessation policies.
A basic tenet of TTM is that to serve entire populations of smokers, programs need to be tailored to the needs of smokers at each stage of change. Research has consistently shown that across adolescent and adult populations in the United States, less than 20% of smokers, for example, are prepared to quit smoking. 6 In nations such as China, Germany, Spain, and Switzerland-which have smoking prevalence rates of more than 30%-less than 5% of adult smokers are prepared to quit. 10 Providing traditional non-tailored, action-oriented interventions would match the needs of only these relatively small segments of populations of smokers. TTM is one of the most commonly applied theories for developing population-based tailored communications. 11 Another finding, the stage effect, has immediate implications for tailoring goals for each stage. 12 The stage effect involves the ability to predict the probability of successful quitting over time, depending on the stage smokers are in at baseline. The classic stage effect involves the amount of abstinence smokers show after treatment as a function of their stage before treatment. In 570 smokers randomly assigned to four different self-help treatments, the stage effect was seen over 18 months with 25% abstinence in smokers in the preparation stage at baseline, 15% in those in the contemplation stage, and only about 8% in those originally in precontemplation. 12 This stage effect with smokers has been replicated with Mexican Americans in small towns in Texas; 13 cardiovascular patients entering the hospital for surgery; 14 middle-aged men in Finland at risk for cardiovascular disease; 15 and patients with head and neck cancer in California. 16 In a recent health maintenance organization (HMO) population of smokers, the stage effect was replicated in 66 of 70 predictions. 17 Helping patients in precontemplation progress to contemplation with a brief tailored intervention can allow them to reach the increased abstinence rates for those in contemplation over time. Such a tailored goal is much more realistic and attainable than trying to persuade or pressure smokers in precontemplation to set a quit date in the next month. A one-size-fits-all action goal for smokers in precontemplation is likely In spite of the serious limitations of such cessation programs, CDC's recommendations guided state health departments to provide quit lines based on features of these action-oriented programs. The predictable consequence of such policies was to support programs that by their very design could not produce much impact. After states such as Delaware, Maine, New Jersey, and Vermont issued RFAs for smoking cessation quit lines, our analyses of their budgets indicated that they were expecting only about one-fourth of 1% of smokers in their states to use these programs each year. Clearly, such cessation programs could have no meaningful public health impact on smoking or on the control and prevention of chronic diseases produced by smoking. to lead to low participation rates, low retention rates, or low abstinence rates. 1 The development of tailored interventions requires assessing the current status of several behavioral change variables. Typical means of assessments include telephone interviews, mailed questionnaires that can be optically scanned, or Internet forms. Staff members enter the data into a computer-based expert system intervention and generate an individually tailored report to help guide people from their current stage to the next stage. In our TTM tailored intervention studies, participants received the first report along with a stage-based self-help manual they could use to progress between interventions. [18] [19] [20] A second assessment and report occurred three to six months later. A third assessment occurred three to six months thereafter, and a final report was generated. Following a complex set of decision rules derived from prior longitudinal studies of how smokers change, the computers assembled the individual reports from a large library of feedback paragraphs available from the expert system.
Typically, the first report is based on a comparison of the responses of the smokers with those of a large sample of successful and unsuccessful quitters. This report relies only on normative comparisons. The norms differ by stages. The initial norms were derived from a naturalistic sample of smokers. Evaluation trials of the expert system provide updated norms at periodic intervals. The second and all subsequent reports compare the smoker with both the normative group and his/her own previous responses, and these reports provide both ipsative (i.e., self-comparisons) and normative comparisons. The ipsative comparisons involve access to the database for the results of the previous contact. A three-to four-page report based on these comparisons contains individualized recommendations for change.
TTM SMOKING CESSATION TRIALS
This section reviews a program of applied research to demonstrate how our TTM tailored interventions have been tested on a variety of populations of smokers and how they have been compared to a variety of alternative interventions. The goal of these studies was to produce increased impacts in populations of smokers. The standard means was a series of three TTM tailored interventions delivered over a 6-or 12-month period plus a stage-matched self-help manual delivered at the time of the initial report. To increase impacts, treatment enhancements (e.g., telephone counselor calls) were added to our best practice intervention of the manual plus three tailored reports.
Study 1: Action oriented vs. stage-tailored treatments
In the first major clinical trial designed to assess the efficacy of the expert system intervention (Study 1), investigators compared the computer-based intervention with a leading action-oriented program for smoking cessation. 18 The stage-matched self-help manual was matched on only one TTM variable-stage. Although this stage-matched manual produced 18% abstinence at 18 months compared with 11% for the standardized action manual, the difference was not statistically significant. The fully tailored expert system that was matched on all 15 TTM variables, however, produced more than twice the abstinence produced by the action manual (24% versus 11%), a statistically significant difference. Surprisingly, stage-tailored telephone counseling did not improve the expert system intervention and produced an abstinence rate no different from that of the stage-matched manual alone (18% and 18%). This was one of the first studies to demonstrate the advantages of tailored communications when compared not with placebo or no-treatment, but with one of the leading home-based treatment programs for smoking cessation, the American Lung Association's non-tailored action-oriented manuals.
Study 1 relied on traditional reactive recruitment that involves advertising the availability of a cessation program and having the smokers initiate contact. The problem with such procedures is that only a small number of smokers respond to such reactive programs (N ϭ 740). In Study 1, therefore, only efficacy could be assessed, and the tailored expert system was the best practice as determined by efficacy.
Study 2: Random Digit Dial (RDD) trial
Subsequent clinical trials used proactive recruitment: the cessation program staff initiated contact to reach out to entire populations at all stages of change to recruit them to behavioral change programs. Combining proactive recruitment with stage-tailored interventions has consistently produced high recruitment rates. When recruitment rates are high, most of the recruits are not prepared to take action. In studies with smokers, for example, more than 40% of the smokers were in the precontemplation stage, about 40% were in the contemplation stage, and less than 20% were ready to quit. 6 With the 80% recruitment rate in the proactive RDD Study 2, our outcomes were remarkably similar to results in the reactive Study 1. 20 With a fully tailored expert system providing three interactive interventions over six months, the abstinence rates at 18 months were 24% for Study 1 and 23% for Study 2. The tailored communication program was significantly more effective than proactive assessment alone at 6-, 12-, 18-, and 24-month follow-ups. More striking were the increasing absolute differences at each follow-up between the treatment and assessment groups. These results suggest that the tailored interventions continued to produce beneficial effects in the population 18 months after the last intervention, which was received at six months. This proactive study shifted our focus from efficacy to impact.
The reactive and proactive studies produced similar efficacy (24% versus 23%), but the impact in the proactive trial was much greater (80% ϫ 23% ϭ 18%). As far as we know, this was the highest impact produced by a cessation intervention.
Study 3: HMO trial
In our next major clinical trial (Study 3), 85% of 4,653 smokers in an HMO-sponsored program were proactively recruited. In one study we compared stagematched manuals and the manuals plus fully tailored expert system communications. 19 These two treatments were compared on four different doses: one, two, three, and six contacts. With each number of doses, fully tailored communications produced more abstinence at every follow-up (at 6, 12, and 18 months) than did the manuals, which were matched only at baseline and only on the stage variable. This was the first study to demonstrate the advantages of maximally tailored interactive communications over noninteractive stagebased manuals while controlling for the number of contacts.
Study 3 also examined dose-response relationships for stage-matched manuals (matched only to the smoker's stage of change) and full TTM-tailored communications. 19 There was no evidence of a doseresponse relationship for either the manuals or the TTM-tailored interventions, nor were there significant differences between doses of one, two, three, and six communication contacts for either type of intervention. This study demonstrated that doubling the number of tailored communications from three to six failed to increase efficacy (23.2% for three contacts versus 19.7% for six contacts).
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Study 4: Counselors plus computers
Another study based on the HMO sample (Study 4) compared computer-generated tailored communications to computers plus counselors. 21 An analysis of the counselors' previous experiences in Study 1 helped us improve the counselor protocol. With the improved protocol, the counselors plus computers outperformed the computers alone at a 12-month follow-up (25% versus 20%), but at 18 months the computers alone were tied with the combined condition (23.2%). The two studies in which counselors were compared with computers suggest that tailored communications from computers may generate greater self-reliance for changing behaviors such as smoking than does dependence on professional counselors. Study 4 also combined stage-tailored computer communications with an actionoriented hand-held computer designed to bring smoking under stimulus control. The stimulus control computer could produce nicotine fading by creating longer and longer durations between each stimulus that cued the smoker to have a cigarette. Combining stage-tailored communication with a standardized actionoriented computer resulted in significantly poorer outcomes than the tailored communication alone (13% versus 23%). These results suggest that adding onesize-fits-all interventions to tailored communications may hurt outcomes when interventions do not actually fit the needs of all smokers, particularly those who are not prepared to quit.
Summary across Studies 1-4
Two consistent findings emerge from the first four studies. First, the computer-based tailored intervention produced a point prevalence smoking cessation rate of 22% to 25% at the end of the study (Figure) . We achieved these results with a total population in the last three studies, and the intervention was of low intensity and delivered at home. A second important finding from the last three studies (involving only two samples) is the high participation rates achieved (80% and 85%).
Study 5: Computers plus the patch
In the next clinical trial, focused on a population of 2,054 smokers in a U.S. Veterans Administration (VA) health care system, we added nicotine replacement therapy (NRT) in the form of over-the-counter patches to the expert system intervention. The combination showed no evidence of increasing efficacy: only 20% were abstinent at 20 months with NRT plus tailored print communications. 22 We also added telecommunications (automated counseling) with computers to the expert system and NRT interventions. This enhanced system called smokers on a set schedule and interacted with them on the telephone, or the smokers called the computers. Still, this combination also failed to increase efficacy, producing 21% abstinence at 20 months. 22 
TTM MULTIPLE BEHAVIOR CHANGE TRIALS
For more than a decade, efforts to increase the efficacy of the best practice of tailored communications for smoking cessation have failed to increase impact. Doubling the number of tailored communication contacts and adding telephone counselors, nicotine fading computers, NRT, and telecommunications have all failed to increase abstinence.
With a real ceiling on recruitment and a practical ceiling on efficacy, impact has not improved since the first population-based clinical trial more than a decade ago. One potential alternative was to treat multiple behaviors in a population, given that populations with multiple behavioral risks are at greater risk for chronic disease and premature death. These populations also account for a disproportionate percentage of health care costs. The best estimates are that about 60% of health care costs are due to about 15% of populations, almost all of whom have multiple behavioral risks. 23 The research literature indicates that changing multiple behaviors on a population basis would be a particularly risky test. A thorough review of the literature funded by the Robert Wood Johnson Foundation failed to find adequate evidence for the consistent efficacy of treating multiple behaviors. 24 Ebrahim and Smith also failed to find support for interventions aimed at multiple behaviors, and they concluded that ". . . such interventions implemented through standard health channels have limited use in the general population. . ." 25 The established wisdom in disease management has been that it is not possible to successfully treat multiple behaviors simultaneously because such treatment places too many demands on a population. 26 The literature to date, however, was limited by reliance on the action paradigm that relies on programs for people prepared to take action, the frequent use of quasi-experimental designs, and the failure to apply the most promising interventions, such as interactive and individualized stage-based tailored communications. 24 Applying the action paradigm to multiple behaviors would indeed risk overwhelming populations: action is the most demanding stage and taking action on two or more behaviors at once could be too demanding for many individuals. But in individuals with four health behavioral risks, such as smoking, diet, sun exposure, and sedentary lifestyles, less than 10% of the population is ready to take action on two or more behaviors. 27 The same thing is true with populations with diabetes who need to change four behaviors. 28 The following paragraphs review the first three studies in a second program of research, to demonstrate how tailored interventions for multiple behaviors can be applied to produce greater impacts in populations at increased risks for chronic diseases. The goal of these trials was to produce significant impacts on multiple behavior risks, including smoking and diet. The means was to apply TTM tailored interventions to each behavior for which an individual was at risk. A series of three tailored interventions for each behavior risk was delivered over a 12-month period. The first two trials also included stage-matched manuals for multiple behavior change, and the third included counselor telephone calls and a series of stage-based newsletters.
Study 1: Cancer prevention in a population of parents
Applying the best practices of a stage-based multiple behaviors manual and three expert system feedback reports over 12 months, we proactively intervened on a population of parents of adolescents who were participating in a parallel project at school. 29 First, the study had to demonstrate that it could proactively recruit a large percentage of parents if impacts were to be great. We recruited 84% (N ϭ 2,460) of the available parents. The treatment group received up to three expert system reports at 0, 6, and 12 months. At 24-month follow-up, the smoking cessation rate was significantly greater in the treatment group (22% abstinent) than in the controls (17%). The parents did even better on diet: 34% progressed to the action or maintenance stage and went from high-fat to low-fat diets compared with 26% of the controls. For sun exposure, 30% of the at-risk parents had reached action or maintenance stages compared with 18% of the controls.
Study 2: Cancer prevention in patients from primary care
With a population of 5,545 patients from primary care practices, we proactively recruited 65% of the available sample for a project to change multiple behaviors. This was our lowest recruitment rate and appeared to result from patients' concerns that project leaders had received their names and phone numbers from their managed care company.
With this population, mammography screening was also targeted, but most of the women older than 50 years were in the action or maintenance stages, and so relapse prevention was the target. We found significant treatment effects for all four targeted behaviors. At 24 months, the smoking cessation rate for the treatment group was 25% compared with 18% for the controls. With diet, 29% of the treatment group had progressed from high-fat to low-fat diets compared with 20% of the control group. 30 With sun exposure, 23% of the treatment group were in action or maintenance compared with 14% of the controls. With mammography screening, twice as many in the control group (6%) as in the treatment group (3%) had relapsed.
Study 3: Diabetes self management
Within a population of Canadian patients with type 1 and type 2 diabetes mellitus, we proactively recruited 1,040 patients to a program to change multiple behaviors for diabetes self-management. 31 Investigators targeted self-monitoring for blood glucose (SMBG), diet, and smoking in this population. Patients were randomly assigned to standard care or a TTM program. The TTM program involved monthly contacts that included three assessments, three expert system reports, three counseling calls, and three newsletter mailings targeted to the participant's stage of change. At the 12-month assessments, the TTM group had significantly more patients in action or maintenance for diet (41% vs. 32%) and for SMBG (38% vs. 25%) With smoking, 25% of the TTM group were abstinent compared with 15% receiving standard care. This difference was not significant because of low statistical power, but the abstinence rate fell within the 22% to 25% rate for programs to change single or multiple behaviors for disease prevention.
SUMMARY AND CONCLUSIONS
This series of eight studies demonstrates that population cessation programs can produce important impacts on smoking cessation for purposes of disease prevention and disease management. These studies also suggest that increased impacts for chronic disease control can be produced by programs that intervene on multiple behavioral risks. Such intervention programs could also increase support for tobacco control policies.
Stages of change and support for tobacco control policies
To assess population support for tobacco control policies, our center developed a Smoking Policy Inventory that reliably and validly assesses support for five types of tobacco control policies: (1) education, (2) controlling youth access, (3) increasing taxes, (4) advertising bans, and (5) smoking bans. 32 One study that looked at six nations found support for tobacco control policies decreased as the policies became more restrictive. 33 In each of the six nations, support for each type of tobacco control policy increased across the stages of change, with the least support among smokers in the precontemplation stage and the most support among former smokers in the maintenance stage. These data suggest that population cessation programs that help smokers progress through the stages of change could also increase support for different types of tobacco control policies. A reciprocal relationship could be generated in which cessation programs increase support for tobacco control policies, and tobacco control policies could help smokers succeed in cessation programs.
In a 2000 National Cancer Institute (NCI) report on population smoking cessation, considerable concern was raised that population cessation rates did not increase in the U.S. during the 1990s, even though the application of tobacco control policies and programs increased dramatically. 34 No improvements in cessation rates were found across any demographic group or type of smoker. There was no improvement in cessation rates in older or younger smokers, African American or non-Latino white smokers, smokers with higher or lower levels of education and income, or in heavier or lighter smokers. To increase the nation's cessation rates, NCI's report recommended that states and communities should increase the frequency, intensity, and/or quality of current tobacco control strategies. 34 The NCI report discovered one other alternative, an individually tailored cessation innovation that has ". . . the potential to provide assistance to the general population of smokers. Interventions based on computer driven algorithms that tailor the intervention and counseling provided to the individual smoker have been developed." Our research suggests that not only could these tailored interventions provide assistance to the general population of smokers, they could also increase support for a broad range of tobacco control policies. As smokers progressed through the stages of change, their support for policies such as increased taxes and counter advertising could increase. They could appreciate how increased taxes could also increase their motivation to quit smoking. They could recognize how counter advertising could help them resist temptations to keep smoking. They could support smoking bans in public places as a strategy that could increase their smoke-free choices, when they are struggling to stay free from smoking.
Increased availability of population cessation programs tailored to the needs of individual smokers and increased support for tobacco control policies have the potential to produce a synergy that could increase cessation rates across a variety of population groups. Research to test these hypotheses is currently under review.
Future policies and programs
Here is an example of how national policy makers can progress toward programs designed to increase population impacts. The senior author had the honor of advising the Prime Minister of Great Britain on smoking cessation programs to prevent cancer and other chronic diseases. The author reported that there are smoking cessation programs available that could reduce smoking prevalence by 20% in two years, even though smoking has decreased in the United States by only about 2% in 12 years.
The Prime Minister asked two key questions: (1) Are these cessation programs based on research with small samples that won't generalize to the real world? and, (2)Are these cessation programs so intensive that few smokers will participate? Here is the leader of a nation asking the most important empirical and practical questions: (1) Are these programs based on clinical trials with small, select samples? and (2) Are these programs that might have adequate efficacy but poor impacts? If policy makers and program sponsors continue to ask such tough questions, they can help raise the standard for health behavioral change theory, research, practice, and policy.
The research reviewed here leads to the recommendation that policy makers support chronic disease programs that shift their primary emphasis:
• from clinical trials to population trials,
• from efficacy outcomes to population impacts,
• from reactive recruitment to proactive recruitment,
• from action-oriented interventions to stagematched interventions,
• from clinician interventions to computer-based interventions,
• from interventions for a single behavior to interventions for multiple behaviors, and
• from policies that coerce change to programs that generate support for policy change.
By shifting our emphasis to population-based interventions, we can build a more effective integration between population smoking cessation policies and programs.
